And yet IgG food panels remain among the most commonly ordered tests in the functional medicine and wellness space. They generate impressive multi-page reports with hundreds of food markers color-coded in alarming reds and yellows. They give patients that actionable feeling of having found the culprits. They cost $200-500. And they’re responsible for some patients spending years on severely restricted diets that address none of their actual biological problems, while generating psychological food anxiety, nutritional inadequacy, and social isolation around eating.
Worth being careful here, though, not to throw out everything at once. Some food sensitivity testing is legitimate. Some food-driven health problems are real and testable. The trick is knowing which tests give actionable information, which conditions have genuine biological diagnostic markers, and when the evidence-based elimination diet is simply the better tool. This piece covers all of it.
The Immunological Alphabet: What IgE, IgG, IgA, and IgM Actually Mean
Understanding food sensitivity testing starts with the basic immunology, because different antibody classes do fundamentally different jobs with completely different clinical implications. Using these terms interchangeably — which is exactly what much of the food sensitivity industry does — produces confusion that leads patients straight to the wrong conclusions.
IgE antibodies mediate true allergic reactions. When the immune system meets a food antigen and decides it’s dangerous, it produces IgE antibodies specific to that protein. Those antibodies coat mast cells and basophils all over the body. On the next exposure to the same protein, cross-linking of IgE antibodies on mast cells triggers immediate degranulation — histamine, prostaglandins, leukotrienes, and other mediators released all at once — producing the classic allergic response within minutes to two hours. Skin prick tests and serum specific IgE testing (ImmunoCAP, formerly RAST) measure IgE antibodies against specific food proteins with validated clinical reliability.
IgE food allergy testing is well-established, diagnostically meaningful, and something clinicians can act on with confidence.
IgG antibodies — specifically the IgG4 subclass most commercial food sensitivity panels measure — tell a completely different story. IgG4 antibodies are produced as part of a normal immune tolerance response. When the immune system regularly encounters food proteins — which it does with every meal, every day — it produces IgG4 antibodies as a marker of ongoing, routine exposure. Not an adverse reaction. The immune system recognizing a familiar dietary constituent and downregulating the potentially inflammatory IgE response to it, through IgG4 “blocking antibodies.” In allergy immunotherapy, IgG4 antibody production is actually the therapeutic goal — the marker of successful desensitization. High IgG4 to a food protein basically means one thing: you eat this food regularly. It does not mean you’re intolerant to it.
And that’s the fundamental error baked into the IgG food panel business model. The test measures a normal immune exposure response and reports it as if it were pathological. Someone who eats eggs daily will have high IgG4 to egg proteins. Someone drinking milk at every meal will have high IgG4 to dairy proteins. A vegetarian eating legumes as their primary protein source will have high IgG4 to bean proteins. The test generates a report identifying “reactive foods” that maps almost exactly onto the person’s regular diet — dressed up in clinical-looking graphs as if it were diagnostic information. When patients eliminate their highest-IgG4 foods, they feel different. Because they’ve made major dietary changes. Not because they’ve fixed a pathological immune reaction. The improvement is real. The mechanism has nothing to do with IgG4.
IgA antibodies — specifically secretory IgA in stool or saliva — represent mucosal immune responses at gut surfaces, and they’re mechanistically different from serum IgG4. Elevated food-specific secretory IgA may indicate an active mucosal immune challenge to a specific food antigen. The clinical relevance is debated, but at least the biological mechanism — a local mucosal reaction rather than a systemic antibody response — is coherent with food reactivity as a mucosal phenomenon. Anti-gliadin sIgA in stool (measured on GI-MAP) and anti-gliadin sIgA in serum (part of celiac testing) are legitimate examples of mucosal IgA testing with established interpretation frameworks.
Legitimate Food Sensitivity and Allergy Testing
Not all food sensitivity testing is pseudoscience. Several tests carry genuine clinical validity, with clear interpretation frameworks and evidence-based management implications.
Celiac disease serology:
Anti-tissue transglutaminase IgA (tTG-IgA) combined with total serum IgA — to rule out selective IgA deficiency, which affects roughly 1 in 300-700 people and would otherwise produce a false-negative celiac serology — is the validated first-line blood test for celiac disease. Sensitivity runs around 95% and specificity around 95% when tested on a gluten-containing diet. Deamidated gliadin peptide antibodies (DGP-IgA and DGP-IgG) add sensitivity, particularly for catching celiac disease in IgA-deficient patients. Positive serology, or high clinical suspicion despite negative serology, means upper endoscopy with small bowel biopsies remains the gold standard for a definitive diagnosis. Celiac disease — an immune-mediated enteropathy affecting roughly 1 in 100 people, with an estimated 83% undiagnosed in the US — is an entirely different animal from IgG food sensitivity: different mechanism, different testing, different management. It’s real, serious, testable with confidence, and treatable with strict gluten elimination.
IgE-mediated food allergy panel:
Skin prick testing and serum specific IgE (ImmunoCAP) measure IgE antibodies to specific food proteins, and both have well-characterized sensitivity and specificity for common allergens. Positive results alongside a consistent clinical history of acute reactions — urticaria, angioedema, vomiting, anaphylaxis within two hours of eating — confirm IgE-mediated allergy with high confidence. Positive results without that clinical history may just mean sensitization without clinical allergy; an oral food challenge under controlled clinical conditions is the gold standard for resolving ambiguous cases.
Lactase deficiency testing:
The lactulose hydrogen breath test — measuring hydrogen produced by gut bacteria fermenting undigested lactose — is the most accurate non-invasive test for lactase enzyme deficiency, the most common cause of dairy intolerance worldwide. The genetic C/T-13910 variant in the LCT gene (testing for lactase persistence) predicts with roughly 90% accuracy whether a person of European ancestry will maintain lactase activity into adulthood. It’s a one-time test that settles the question of expected lactase persistence, without requiring the dietary challenge and symptom provocation a breath test demands.
HLA-DQ2/DQ8 genotyping:
These HLA variants show up in virtually all celiac disease patients. Their absence effectively rules out celiac disease — negative predictive value above 99%. Most useful for people who already eliminated gluten before celiac serology was ordered, which makes antibody tests unreliable. HLA-DQ2/DQ8 genotyping answers the underlying question — can this person even have celiac disease? — without requiring the gluten reintroduction patients understandably resist. The catch: roughly 30-35% of the general population carries DQ2 or DQ8 without having celiac disease, so a positive genotype is necessary but not sufficient for diagnosis.
Mast cell activation syndrome (MCAS) evaluation:
Multiple food and environmental reactions — particularly with non-GI symptoms like flushing, urticaria, palpitations, neurological symptoms, and anaphylactoid episodes without IgE-mediated allergy behind them — warrant an MCAS workup. Testing includes serum tryptase (must be drawn within 1-4 hours of a symptomatic episode; baseline tryptase is often normal in MCAS), 24-hour urine prostaglandin D2 (the most sensitive MCAS marker), 24-hour urine N-methylhistamine, and serum chromogranin A. These markers capture mast cell degranulation activity directly — a completely different mechanism from IgG antibody testing, with its own specific pharmacological treatment implications: H1 and H2 antihistamines, cromolyn sodium, ketotifen, quercetin as a mast cell stabilizer.
The Elimination Diet: The Actual Diagnostic Gold Standard
Before getting further into testing, a fundamental fact about diagnostic methodology worth stating plainly: the gold standard for identifying food-driven symptoms isn’t any laboratory test. It’s the structured elimination diet with systematic reintroduction challenges. Has been for decades, and remains true despite every advance in laboratory technology since. The elimination-reintroduction protocol is evidence-based, free of false positives by design — only foods that genuinely cause symptoms in a given person will produce a positive result — and gives clinically actionable information that guides permanent dietary decisions with more confidence than any antibody panel.
The structured protocol, for maximum diagnostic yield:
Elimination phase (minimum 3 weeks, optimally 4-6):
Complete removal of the most common immunological and pharmacological food triggers — gluten and wheat products, dairy in all forms, eggs, tree nuts, peanuts, soy, shellfish, fish, corn, nightshade vegetables (tomato, pepper, eggplant, potato), and often refined sugar and alcohol. The elimination has to be complete and strict. Trace exposures — shared cooking surfaces, restaurant cross-contamination, hidden gluten in sauces — will invalidate the whole test. Most patients with genuinely food-driven symptoms see meaningful improvement during this phase; if they don’t, food is probably not the primary driver, and the search should shift toward gut pathology, hormonal factors, or something else entirely.
Systematic reintroduction (one food at a time, 3-4 days per food):
Reintroduce one eliminated food in a substantial quantity — eat it at two consecutive meals — on the reintroduction day, then watch for three days before moving to the next food. Delayed reactions, which can show up 4-72 hours after exposure with non-IgE mechanisms, need that three-day window to get attributed correctly. Document any symptom recurrence carefully: timing, type, severity. Symptoms returning with a specific food, resolving again when it’s removed, is the diagnostic evidence that food is a trigger.
Confirmation challenge:
For any food flagged as a trigger, a second elimination and reintroduction 2-4 weeks later confirms the finding and rules out coincidence. Worth the extra step for anything that’s going to be permanently avoided — the lifestyle cost justifies the confirmation.
The obvious limitation of the elimination diet: it takes real patient motivation, real planning, and 8-12 weeks of committed adherence to do properly. For patients unwilling or unable to complete a full structured elimination, lab testing can at least offer a starting hypothesis for where to focus a shorter trial. That’s the rational use of an imperfect test — a hypothesis generator for a targeted elimination — not a standalone diagnostic.
Histamine Intolerance: A Food Reaction Without Antibodies
The mechanism: dietary histamine from fermented, aged, or microbially processed foods, combined with histamine liberated by certain other foods (alcohol, shellfish, strawberries, spinach, and tomatoes release histamine from mast cells), has to get degraded primarily by the enzyme diamine oxidase (DAO) in the gut epithelium before it reaches systemic circulation. When DAO activity falls short — from genetic DAO variants, gut inflammation reducing DAO-producing enterocyte populations, DAO-inhibiting medications (certain antihistamines, paradoxically, ACE inhibitors, NSAIDs, antidepressants), or alcohol directly inhibiting DAO — histamine accumulates systemically and produces symptoms that mimic an allergic reaction.
Symptoms span multiple organ systems, because histamine receptors (H1, H2, H3, H4) are everywhere: flushing, headaches (particularly migraines), urticaria (hives), nasal congestion, GI symptoms (cramping, diarrhea), heart palpitations and tachycardia, anxiety, fatigue, and dysmenorrhea. Histamine is a potent uterine smooth muscle contractor, which is why histamine intolerance tends to worsen significantly premenstrually — the COMT enzyme that degrades catechol estrogens and catecholamines also degrades histamine, and it gets overloaded. The foods highest in histamine or histamine-liberating compounds: aged cheeses, red wine and beer (alcohol also inhibits DAO), fermented foods (sauerkraut, kimchi, kombucha), cured and processed meats, canned fish and smoked salmon, vinegar, and leftover cooked proteins (histamine accumulates in foods during microbial fermentation, including the bacteria that start fermenting any cooked protein left sitting at room temperature).
Testing for histamine intolerance: serum DAO enzyme activity is available through several labs. Low DAO activity combined with a symptom history that matches histamine-containing food triggers supports the diagnosis. The AOC1 gene polymorphism rs1049742 (reduced DAO enzyme activity from a genetic variant) is testable through 23andMe raw data with the right bioinformatics analysis. Neither test is sufficient alone — clinical history remains the primary diagnostic criterion, with lab testing offering confirmatory biological context.
Management: a low-histamine diet, avoiding the high-histamine foods listed above; a DAO enzyme supplement taken before high-histamine meals (reducing the degradation lag that produces symptoms); quercetin, a mast cell stabilizer that reduces histamine release from mast cells in the gut wall and so cuts one upstream source of the histamine load; vitamin C (a DAO cofactor and histamine degrader); and addressing whatever gut inflammation is reducing DAO-producing enterocyte populations in the first place — the same gut barrier support protocol that improves secretory IgA also restores DAO production.
Non-Celiac Gluten Sensitivity: Real but Difficult to Diagnose
Non-celiac gluten sensitivity (NCGS) is a legitimate clinical entity, defined as a symptomatic response to gluten without celiac disease autoimmunity or wheat IgE allergy present. Some researchers estimate it affects 6-10% of the population, though the figure is contested and depends heavily on how rigorously placebo effects get controlled for. The entity itself is genuine. Its precise prevalence and mechanism remain up for debate.
The diagnostic challenge: there’s currently no validated biomarker for NCGS. Unlike celiac disease (tTG-IgA autoantibody) and wheat allergy (IgE to wheat proteins), NCGS has no specific antibody, genetic marker, or histological finding defining it. It gets diagnosed by exclusion — ruling out celiac disease and wheat allergy, then documenting symptomatic improvement on gluten removal with symptoms returning on a blinded gluten reintroduction challenge. That double-blind, placebo-controlled challenge is the methodologically rigorous standard, but it’s logistically difficult to pull off outside a research setting.
Then there’s the Biesiekierski complication. A 2013 double-blind crossover trial published in Gastroenterology gave patients who believed they had NCGS either gluten or a placebo matched for FODMAP content — and gluten produced no worse symptoms than the placebo. That suggested the response many NCGS patients attribute to gluten may actually be a response to fructans (a FODMAP fermentable carbohydrate in wheat) rather than to gluten protein itself. This hasn’t discredited NCGS entirely — other researchers have found gluten-specific responses in methodologically rigorous designs — but it’s complicated the picture and suggests some “NCGS” cases might be more precisely described as fructan intolerance.
For the clinician and patient: the elimination-reintroduction protocol can distinguish NCGS from fructan intolerance by separately challenging with gluten-containing/high-fructan foods (wheat bread) versus low-fructan gluten sources (pure gluten capsules) versus high-fructan gluten-free foods (onion, garlic). Rarely done with that level of granularity in actual practice, but it’s the most precise way to pin down what’s actually triggering symptoms.
FODMAP Intolerances: The Carbohydrate Fermentation Framework
FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) are a class of fermentable carbohydrates that are poorly absorbed in the small intestine and get rapidly fermented by colonic bacteria — producing gas, osmotic fluid shifts, and the intestinal distension that triggers IBS symptoms in people with visceral hypersensitivity. Not an immune reaction. A fermentation-driven mechanical and osmotic process, plain and simple.
The low-FODMAP diet, developed by researchers at Monash University in Australia, is the most evidence-based dietary intervention for IBS symptoms available. Multiple randomized controlled trials have shown 50-70% symptom reduction in IBS patients following the low-FODMAP approach. The specific fermentable carbohydrate categories: fructose (fruits, honey, high-fructose corn syrup — the problem is excess fructose relative to glucose); lactose (dairy — the “disaccharide” piece); fructans (wheat, onions, garlic, asparagus — also the source of the FODMAP-NCGS confusion); galacto-oligosaccharides (legumes, lentils); and polyols (sorbitol, mannitol, xylitol in fruits and sugar-free products).
No antibody test identifies FODMAP intolerance. The breath hydrogen test — measuring hydrogen from colonic fermentation after standardized carbohydrate challenges — can document fructose malabsorption and lactose malabsorption specifically, but it’s not routinely run for every FODMAP carbohydrate. Clinical identification requires a structured low-FODMAP elimination followed by systematic category reintroduction, to figure out which specific FODMAP categories are the problem for a given individual — a process the Monash University FODMAP App makes considerably easier, with precise food FODMAP content data built in.
Salicylate and Chemical Intolerances: Beyond Immunological Reactions
Not every food reaction is immunological or carbohydrate-fermentation based. A meaningful subset of patients react to naturally occurring food chemicals — mainly salicylates, amines (histamine, tyramine, phenylethylamine), glutamates, and oxalates — through pharmacological rather than immunological mechanisms. These “food chemical intolerances” are invisible to every antibody-based and genetic testing approach out there.
Salicylate intolerance (formally aspirin-exacerbated respiratory disease when it hits the respiratory tract, or non-immune salicylate sensitivity in GI and skin presentations) affects a subset of people who can’t metabolize salicylic acid derivatives at the rate a high-salicylate diet demands. Salicylates run high in plenty of plant foods — herbs and spices especially (turmeric, curry, paprika, ginger), some fruits (berries, grapes, stone fruits), vegetables (tomatoes, broccoli, zucchini), and teas. They inhibit cyclooxygenase enzymes — the same mechanism as aspirin and NSAIDs — producing prostaglandin shifts that drive nasal polyps, asthma exacerbation, urticaria, and GI symptoms in sensitive people. The tell is reactions to seemingly healthy, plant-based foods with no obvious common immunological thread. A low-salicylate dietary trial — developed within Sue Dengate’s Failsafe diet framework — is the diagnostic and therapeutic approach here; no lab test specifically identifies salicylate intolerance.
Tyramine sensitivity produces migraines, palpitations, hypertension, and anxiety after eating tyramine-rich foods — aged cheeses (particularly hard cheeses), cured meats, fermented foods, broad beans, red wine. Tyramine is a sympathomimetic amine that triggers catecholamine release. Normal MAO-A enzyme activity (regulated by the X-linked MAOA gene) rapidly degrades tyramine before it can cause systemic effects; people with reduced MAO-A activity — from a genetic polymorphism or from MAO inhibitor medication — get pronounced tyramine reactions. The pharmacological interaction with MAO inhibitor antidepressants (phenelzine, tranylcypromine, selegiline) is well established; the genetic MAOA low-activity variant produces a similar but milder tyramine sensitivity without any medication involved. No blood test diagnoses tyramine sensitivity — dietary elimination and challenge is the method.
MSG (monosodium glutamate) sensitivity — colloquially “Chinese restaurant syndrome” — has a controversial evidence base. Early anecdotal reports of MSG-triggered symptoms weren’t confirmed in blinded clinical trials at the doses actually present in food. Current scientific consensus is that MSG sensitivity as a clinical entity is poorly supported by controlled research for most patients. That said, there’s a specific subset of people with elevated glutamate sensitivity — including some autistic individuals and people with certain neurological conditions — who may respond to dietary glutamate modulation through distinct neurological mechanisms the MSG-specific studies never addressed. The nuance matters here: dismissing all glutamate sensitivity based purely on the MSG literature overcorrects just as badly in the opposite direction from the food sensitivity industry’s overclaiming.
The Gut Dysbiosis-Food Reactivity Connection
One of the more important insights in food reactivity medicine: many patients with apparent food sensitivities — especially those reacting to a wide and shifting roster of foods — don’t have primary food intolerances at all. They have gut dysbiosis, impaired intestinal permeability, or diminished mucosal immune function driving secondary food reactivity. The distinction matters enormously, because it changes what actually gets targeted.
When the intestinal epithelial barrier is compromised — elevated zonulin, reduced tight junction protein expression, reduced mucosal immune defense from low secretory IgA — incompletely digested peptides from food proteins cross into the lamina propria and trigger immune responses. Foods that would be fully digested and tolerated with an intact barrier become antigenic once larger peptides start crossing through. Not because of any intrinsic incompatibility with those particular foods — because the gut barrier itself is failing. The fix is restoring gut barrier integrity. Not eliminating whatever happens to be crossing through an impaired barrier at the moment.
The practical takeaway: when a patient shows up with broad, multi-food reactivity across many different food categories — especially if the pattern shifts over time, developed acutely after an illness, antibiotic course, or period of severe stress, or doesn’t map cleanly onto any specific immunological or pharmacological mechanism — gut evaluation with GI-MAP and gut barrier assessment should come before any extensive food sensitivity testing. Treat the gut first. Reassess food tolerances after.
The RWS Food Reaction Diagnostic Framework
A systematic way to identify the mechanism most likely behind food-related symptoms — which determines what testing actually makes sense and what intervention is most targeted:
- Timing of reaction: Minutes to two hours after exposure: IgE-mediated allergy — allergist evaluation, skin prick testing, specific IgE measurement. Four to seventy-two hours after: T-cell mediated (celiac), NCGS, FODMAP fermentation, or histamine intolerance. This delayed pattern often produces inconsistent symptom attribution, because the exposure and the reaction sit hours or days apart.
- Symptom character: GI-dominant with bloating, gas, altered motility: FODMAP, lactase deficiency, or gut dysbiosis. Systemic with flushing, urticaria, headache, palpitations: histamine intolerance or MCAS. Neurological dominant (brain fog, mood, anxiety): celiac, NCGS, histamine, or gut dysbiosis-driven neuroinflammation via the gut-brain axis. Multi-system, hitting organs that don’t obviously connect: MCAS or gut barrier dysfunction letting broad systemic immune activation loose.
- Food pattern specificity: Symptoms consistently following fermented, aged, or alcohol-containing foods: histamine intolerance framework. Wheat-specific symptoms with no dairy, egg, or other triggers: celiac or NCGS framework (test for celiac before pulling gluten). Dairy symptoms that scale with dose — small amounts fine, large amounts not: lactase deficiency framework. A wide variety of seemingly unrelated foods, especially recently developed: gut barrier dysfunction or MCAS.
- Rule out celiac disease first, before removing gluten: tTG-IgA with total IgA, on a gluten-containing diet. Once gluten is eliminated, celiac serology stops being reliable. Celiac disease is both underdiagnosed and carries implications beyond diet — screening for complications, screening first-degree relatives — that make an accurate diagnosis worth getting right.
- Proceed to structured elimination diet if celiac is negative: the elimination-reintroduction protocol gives more reliable food reactivity identification than any currently validated blood test, for the non-celiac, non-IgE presentation.
- Consider functional gut assessment: for multi-food reactivity or persistent symptoms, GI-MAP to identify gut pathology potentially driving secondary food reactivity, plus an organic acids test for gut microbial metabolic markers. Treating the underlying gut condition frequently resolves the apparent food sensitivities on its own.
What People Ask About Immunological Alphabet IgE
- Are IgG food tests completely useless?
The honest answer has some nuance to it. They don’t diagnose food intolerance the way they’re marketed to. That said, some practitioners use high-IgG4 results as a starting point for designing an elimination diet — the logic being that removing the foods eaten most often provides a structured framework for a dietary trial. Rational enough, if the limitations are fully understood and communicated, and if the test is treated as an elimination-protocol guide rather than a diagnosis. The problem is that most practitioners, and nearly all patients, treat the results as definitive diagnoses. The panel failing as a diagnostic test doesn’t mean the elimination period that follows is worthless — it means whatever improvement shows up isn’t coming from removing “IgG4-reactive” foods specifically. - Why do people feel better after removing IgG-positive foods?
Several valid explanations exist at once. Many high-IgG4 foods are heavily processed (bread, dairy products, corn, soy) — removing them improves overall diet quality independent of any specific immune mechanism. The nocebo effect is real; believing a food harms you can genuinely produce symptoms when you eat it. Foods removed concurrently may include actual triggers (wheat removal from an IgG panel result will catch NCGS or FODMAP sensitivity in people who actually have it). Reduced caloric density from cutting processed foods may improve metabolic markers on its own. None of it requires IgG4 as a causal mechanism. - What is the best test for small intestinal bacterial overgrowth (SIBO)?
SIBO isn’t caught by food sensitivity testing of any kind. The standard non-invasive test is the hydrogen and methane breath test, using lactulose or glucose substrate, measuring H2 and CH4 production by bacteria in the small intestine. The glucose breath test has higher specificity — glucose is fully absorbed before reaching the colon, so any H2 elevation has to reflect small intestinal bacteria — while the lactulose test has higher sensitivity, catching bacteria throughout the small intestine. Methane-producing organisms (CH4 elevation) produce constipation-predominant SIBO, a clinically important pattern requiring specific antibiotic selection — rifaximin plus neomycin, versus rifaximin alone for the hydrogen-predominant type. SIBO shows up significantly with functional GI symptoms, malabsorption, and IBS, and addressing it is often more important than any food elimination. - Should I avoid gluten even without confirmed celiac disease?
Only with documented symptomatic improvement on gluten removal, confirmed by blinded or open reintroduction challenge. Arbitrary gluten elimination without documented sensitivity is unnecessary restriction with real downsides — reduced whole grain fiber intake, nutritional inadequacy (gluten-free products typically run lower in B vitamins, fiber, and minerals than their wheat counterparts), higher cost, social complications, and food anxiety. The reflexive anti-gluten trend has done real harm by stigmatizing wheat nutrition for non-sensitive people, while simultaneously distracting from the legitimate celiac and NCGS cases that genuinely need strict avoidance. - Can food sensitivities develop in adulthood?
Yes, through several mechanisms. Adult-onset IgE food allergy is documented, particularly for shellfish, tree nuts, and alpha-gal (mammalian meat allergy triggered by lone star tick bites). Celiac disease can emerge at any age. Histamine intolerance may worsen with age as DAO activity declines. MCAS can develop following infections, surgeries, or significant physiological stress. Most significantly, gut dysbiosis from antibiotic use, severe illness, or prolonged psychological stress can produce new food reactivity in someone previously tolerant, by compromising gut barrier function — the post-antibiotic food sensitivity pattern shows up constantly in clinical practice, and it should trigger a gut assessment, not permanent food elimination.
The MRT (Mediator Release Test) deserves a mention as a more methodologically serious food reactivity test than standard IgG panels. It measures volume changes in whole blood after incubation with food antigens — theoretically reflecting mediator release from multiple immune cell types, not just IgG-mediated reactions. Unlike IgG4 tests, the MRT was specifically developed as a food sensitivity test and carries more clinical validation, including a 2015 IBS pilot study showing meaningful symptom improvement with MRT-guided dietary therapy. The Oxford Biomedical Technologies LEAP program, built on the MRT, is the most clinically developed implementation of it. More expensive ($300-450) and more technically demanding than IgG panels, but with a more defensible evidence base behind it. Still a second-line investigation compared to the elimination diet — but for patients who can’t complete the full elimination protocol, MRT-guided elimination is a more evidence-grounded alternative than standard IgG panels.
The broader lesson from food reactivity medicine is that “food sensitivity” isn’t a single biological phenomenon. It’s a category label covering at least eight distinct mechanisms — IgE allergy, celiac autoimmunity, NCGS, FODMAP fermentation, lactase deficiency, histamine intolerance, MCAS, and gut barrier dysfunction with secondary reactivity — plus the food chemical intolerances on top, each needing a different diagnostic approach and a different management strategy. Treating “food sensitivity” as one unitary diagnosis with one unitary test is the category error that lets IgG panels keep selling despite their fundamental inadequacy. Asking what mechanism is actually driving a given person’s reaction to food, before ordering anything, is the clinical competence that leads somewhere.
The food sensitivity testing industry pulls in roughly $2 billion a year. Not all of it is bad science — plenty represents legitimate testing done by responsible practitioners in appropriate clinical contexts, accurately interpreted and productively guiding treatment. But a meaningful chunk is marketing-driven pseudoscience, capturing suffering patients’ hope and money while pointing clinical attention toward food elimination instead of whatever’s actually driving the illness.
The first principle of diagnostic testing is that a test is only useful if acting on its results leads to better outcomes than not testing at all. By that standard, most IgG food panels fail for the majority of people who take them. The elimination diet remains free, evidence-based, false-positive-free by construction, and more reliable than any antibody panel for identifying food-driven symptoms in the non-celiac, non-IgE presentation. That it’s less profitable explains its relative neglect in commercial marketing. That it takes patient effort and practitioner time explains its relative underuse in the clinic. Neither is a scientific reason to prefer an unreliable test over a reliable process. Know what’s being bought before spending the money — and know that the tool that works best usually costs nothing, but demands something money can’t buy: the patience to do the work properly, and the willingness to go without easy answers long enough for the real ones to surface.
The Practical Framework: Applying Immunological Alphabet IgE IgG In Real Life
FROM THE LIBRARY ›
References
Editorial StandardsCorrectionsMedical DisclaimerAbout Our ContentAffiliate DisclosureSite Map